Once reserved for very high-risk patients, the use of transcatheter aortic valve replacement in low-risk cases has increased ...

Study validates a new risk model that allows for more accurate risk estimates, encourages shared decision-making, and helps ...

Pulmonary hypertension patients who undergo transcatheter aortic valve replacement are at a higher risk for mortality than those without pulmonary hypertension, according to a recent study.

Ohio hospitals are evaluating their transcatheter aortic valve replacement programs after recent data showed a higher mortality rate and cost than average, the Scioto Valley Guardian reported May 17.

TAVR is a less invasive procedure than traditional open-heart surgery, offering faster recovery, reduced risk, and shorter ...

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...

Aortic stenosis is when the heart’s main valve becomes stiff and narrowed, making it harder for blood to flow to the rest of the body. When it becomes severe, it can lead to life-threatening ...

PARIS -- Patients with questionable suitability for transcatheter aortic valve replacement (TAVR) in fact fared worse in the short term after the catheter-based procedure than after surgery, the ...

For the rising number of patients needing aortic reintervention, transcatheter aortic valve replacement (TAVR) explantation carried the highest mortality risk, two registry analyses affirmed. In ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with transcatheter aortic valve replacement ...

PLYMOUTH MEETING, Pa. (WPVI) -- The TAVR procedure has revolutionized a challenging task in heart care: fixing stiff valves. And it has made the process much easier for patients, getting them back to ...

Edwards Lifesciences has claimed a groundbreaking approval from the FDA that opens up its minimally invasive heart valve implants to patients before they begin to show cardiac symptoms. The company ...